Cell Genesys (CEGE)

All Comments on CEGE

  • commenter
    Daniel
    Haszard
    Aug 28 01:23 PM
    My Website
    Five Biopharma Companies Drop on Negative Drug News [view article]
    Zyprexa has generated a lot of bad press for Eli Lilly and they still have unresolved Zyprexa settlement claims.
    Eli Lilly is 'reaping the whirlwind' for aggressive marketing of Zyprexa that has caused suffering and deaths.
    Zyprexa is being avoided by doctors they aren't prescribing it for new patients at all anymore.
    --
    Daniel Haszard 4 year Zyprexa patient who got diabetes from it.     Reply
  • commenter
    Olboy2
    Aug 13 02:56 PM
    Cancer Stocks on the Go: Winners and Losers [view article]
    I agree with paviov, However I would like to know about the new developments the phase II and III studies that are going well, where is the advancement taking place, how close to a cure, what company has the potential winning drug ?? Reply
  • commenter
    biofest
    May 19 04:14 AM
    Cell Genesys, Inc. Q1 2008 Earnings Call Transcript [view article]
    Thanks for transcript. News seems very positive but I wish Steve would not raise money from institutions on very goods for the institutions without giving longterm shareholders the chance to participate. I am talking about the money raised at $4.22 including warrants to buy shares at $10. Reply
  • commenter
    BILLCUBFAN
    May 13 08:38 AM
    Six Significant Gene Therapy Stocks [view article]
    CEGE HAS THE POTENTIAL TO HIT $8.00 T0 $8.50 THIS YEAR AND THE SKYS THE LIMIT IN 09. Reply
  • commenter
    Jake Blues
    May 13 06:58 AM
    Six Significant Gene Therapy Stocks [view article]
    I'd say CEGE has the best chance to be multi-bagger. I've been watching ISIS for quite some and may pick up some shares later this quarter. Reply
  • commenter
    biofest
    May 01 04:50 AM
    Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals [view article]
    Utter nonsense is a good discription of razormd's contribution. Where are the facts to support his position? Reply
  • commenter
    Ohad Hammer
    Apr 28 02:10 PM
    My Website
    Cell Genesys’ GVAX: A Multi-Trick Pony [view article]
    Hi Ethan,

    Thanks for the kind words.
    I don't think there will be any new meaningful data on the conference call . I think that the partnrship is already priced in but predicting short term performance is very hard with this type of companies.
    The comapny is going to present data on its oncolytic virus program in bladder cancer next month at the AUA2008, so it looks like the nearest potential catalyst (positive or negative).

    Reply
  • commenter
    salfi 68
    Apr 25 03:33 PM
    Cell Genesys’ GVAX: A Multi-Trick Pony [view article]
    hello mr hammer

    i find yr article very enlightening - had i known half of this info earlier i don't know if i would have encouraged my father to take part in the trail (he is now fighting to keep in contact with our world - being able only to move his toes and to breathe heavily to let me know he can here me by telephone - he has lost his speech in the space of 48hrs!)

    thks for being honest
    salfi68     Reply
  • commenter
    EBrookes
    Apr 25 01:28 PM
    Cell Genesys’ GVAX: A Multi-Trick Pony [view article]
    Hi Mr. Hammer,

    I too liked your article and found it very informative. If I may ask, do you expect CEGEs stock to rise or fall after the May 1st conference, compared to the high 3s it currently is trading at?

    Ethan     Reply
  • commenter
    Ohad Hammer
    Apr 14 01:45 PM
    My Website
    Cell Genesys’ GVAX: A Multi-Trick Pony [view article]
    Thanks.
    Overall the deal is positive given market conditions. Neverheless, I think they could have got this deal at least one year ago and save a terrible year for investors.
    Reply
  • commenter
    steveb
    Apr 13 10:08 PM
    Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals [view article]
    Why the DNDN slam? at least they are running double blind randomized studies unlike CEGE...who are data mining experts.You Mr. Shulman are an idiot! Reply
  • commenter
    razormd
    Apr 13 10:16 AM
    My Website
    Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals [view article]
    Utter nonsense!...getting drug approval in Russia and many other companies is nothing more than a matter of seeing that the appropriate amount of silver crosses the right palms...they could care less the ultimate consequences...and although the FDA is strict, they NO doubt SAVE many more times the number of lives with their protocols than lose lives due to a POTENTIALLY beneficial therapeutic not making it through the sieve!...and were they not so strict we would be overrun by every kind of charlatan drug pusher and quack device scam imaginable at a financial cost to consumers of who knows how many billions. Reply
  • commenter
    dslnbull
    Apr 12 02:29 PM
    Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals [view article]
    This report should be in the front page of all news paper. FDA here to kill the americans and to get bribe for the politician. Reply
  • commenter
    dslnbull
    Apr 12 02:21 PM
    Russian Roulette Pays Off for Antigenics [view article]
    DNDN should try to get approval from russia, india middle east....American can fly get treatment.They can boost their economy. Reply
  • commenter
    zuludoc
    Apr 11 06:37 PM
    Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals [view article]
    Your comments are excellent! It might be good to review cancer staging and its clinical significance. There is such a thing as too late.
    It is very important with respect to cancer therapy of any kind.     Reply

Trading Center


Loading...
Symbols:
Authors:
Quick Links: